BOLD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Boundless Bio Inc (BOLD) is not a strong buy for a beginner, long-term investor at this time. The stock shows no significant positive trading trends, lacks recent news or catalysts, and has weak financial performance. Additionally, there are no proprietary trading signals or influential trading activity to support an immediate buy decision.
The technical indicators are neutral. The MACD is slightly positive but contracting, RSI is at 52.108 (neutral zone), and moving averages are converging. The stock is trading near its pivot level of 1.152, with no clear breakout or breakdown signals.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance in Q3 2025, with a net income drop of -15.93% YoY and EPS decline of -16.22% YoY. No recent news or influential trading activity to drive positive sentiment.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$13.88M (-15.93% YoY), and an EPS decline of -16.22% YoY. Gross margin remains at 0%. Overall, the financials indicate poor performance.
No data available for analyst ratings or price target changes.
